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Abstract
Background: This study is the first documented prevalence of  IgG antibody against HSV-1&-2 in Port Harcourt, Nigeria 
and thus provides baseline data for future in-depth studies on HSV infection in South-South, Nigeria. 
Objective: This study determined the seropositivity and determinants of  serum IgG antibody against HSV-1 & HIV-2 
among pregnant women attending BMSH, Port Harcourt, Rivers State, Nigeria.
Methods: Serum samples from 180 pregnant women attending antenatal clinic at Braithwaite Memorial Specialist Hospital 
(BMSH) in Port Harcourt, Nigeria. Serum samples were analysed with commercial HSV type-1&-2 specific IgG Enzyme 
Linked Immunosorbent Assay (ELISA) kits. Chi-square analysis was used to determine the association of  infection with 
socio-demographic variables. 
Results: Of  the 180 pregnant women, 179 (99.4%) were seropositive and 1(0.6%) was seronegative for HSV 1&2 IgG an-
tibody. No statistical association existed between the prevalence of  HSV-1&-2 IgG antibodies and the socio-demographic 
variables studied (p>0.05) except for marital status which was significantly associated (p<0.05). 
Conclusion: Our data shows that HSV-1 & 2 seropositivity among pregnant women in Port Harcourt is high; thus serolog-
ical screening for HSV-1&-2 might be advisable for antenatal attendees. 
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Introduction
Amongst the human viral infections all over the world, 
herpes caused by herpes simplex virus (HSV) types-1 
and HSV-2 were the most common 1. They are one of  
the most common viral sexually transmitted diseases 
(STD) worldwide2-3 and are now a major public health 
concern, established by the widespread of  genital HSV 
and heightened acquisition of  human immunodeficien-
cy virus (HIV) infections in connotation with HSV ac-
quisition4-5.
It has been projected that 90% of  individuals globally 
remain seropositive for HSV-1 by the fourth decade of  
life, particularly persons within low socio-economic lev-
els6. An estimate of  536 million people or approximate-
ly 16% of  the population of  the world in the age group 
15-49 years have been shown to be living with HSV-2 
worldwide7. More women than men have been shown 
to have acquired the virus7. A projection of  315 mil-
lion females has been reported to be infected with HSV 
paralleled to an estimate of  221 million infected men7. 
The lowest prevalence was found in Western Europe, 
where prevalence reached a maximum of  around 18% 
among women and 13% among men while the highest 
prevalence was in sub-Saharan Africa, where prevalence 
reached a maximum of  70% among women and around 
55% among men7. 
In order to properly manage herpes patients and de-
velop approaches to avert spread of  HSV, efficient se-
rological testing is pertinent. The finding of  type-par-
ticular antigens in HSV-1 and HSV-2, remarkably IgG 
antibodies, has remained effectively used to advance 
tests for the determination of  particular HSV antibody 
[8]. The existence of  particular antibodies offers proof  
of  HSV-1, HSV-2, or HSV-1 and HSV-28. The seroposi-
tivity and determinants of  IgG antibodies against HSV-
1 &-2 amongst these pregnant women were examined 
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using commercially available enzyme linked immunoso-
bernt assay (ELISA) kits.
Methods
Study area
The current study was steered from February 2013 to 
September, 2013 and was restricted to pregnant women 
presenting at the antenatal clinic of  Braithwaite Memo-
rial Specialist Hospital, Port Harcourt, Nigeria. BMSH 
is a government owned specialist hospital which is lo-
cated in the old Government Reserved Area (G.R.A.) 
of  Port Harcourt City. It is a frequently used hospital 
in Rivers State, which by feature of  its setting delivers 
tertiary health-care services. Port Harcourt lies along 
the Bonny River in the Niger Delta and it coordinates 
are 4°53’23”N 6°54’18”E and located in a city 360 km2 
(139 sq mi). 
Study plan
This is a consecutive hospital based study which was 
implemented to determine the seropositivity of  IgG 
antibodies against HSV-1 and HSV-2 amongst pregnant 
women in Port Harcourt, South South, Nigeria. 
Study population
The targeted populace consist of  all the pregnant wom-
en presenting at the antenatal clinic of  BMSH from 
February to September, 2013. A total of  180 consented 
pregnant women were carefully chosen and registered 
for the study. The sociodemographic data were collect-
ed from their medical registers (Table 1). The informa-
tion obtained were stratified as follows; the ages of  the 
pregnant women were grouped into four groups- 20-25 
years, 26-30 years, 31-35 years and 36-42 years; the mar-
ital status was classified as being married or single; the 
educational status was grouped into primary, secondary, 
post-secondary and tertiary education while occupa-
tional status was grouped as employed, self-employed, 
unemployed and students. Finally, the gestation periods 
were classified based on the trimesters the women were 
in at the time of  the study; first, second or third trimes-
ters.
Collection and preparation of  samples
Five milliliters of  venous blood were collected into ster-
ile tubes from the enrolled subjects. These samples were 
centrifuged for 15 minutes and resultant sera were ex-
tracted into labelled eppendorf  tubes. Sera were stored 
at temperature of  -20OC until use. 
Serology
Sera were examined for IgG antibodies against HSV-
1 & HSV-2 using a commercially available ELISA kit 
manufactured by DIA.PRO Diagnostic Bioprobes Srl 
Via G. Carducci no 27 20099 Sesto San Giovanni, Mi-
lano, Italy. These tests were implemented as specified by 
the manufacturer.
Principle of  the test
The HSV 1&2 IgG ELISA kit was built on the principle 
of  IgG capture in which the microplates were coated 
with native inactivated HSV-1 and HSV-2. The dense 
stage was mainly treated with the weakened sample and 
anti-HSV IgG were taken, if  existing, by the antigens. 
Subsequently washing out all the other constituents of  
the sample. In the second incubation, linked anti-HSV 
IgG were identified by adding polyclonal specific an-
ti-hIgG antibodies, branded with peroxidase (HRP). 
The enzyme apprehended on the compacted segment, 
performing on the substrate/chromogen mix, creates 
an optical indicator that is proportionate to the quantity 
of  anti-HSV IgG antibodies existing in the sample. A 
calibration curve plotted alongside a core gold stand-
ard, creates potentially, a quantifiable IgG antibodies 
determination in the sample. Interpretation of  results 
were done as specified by the manufacturer.
Data analyses
Outcomes were presented and scrutinised using Statis-
tical Package for Social Sciences (SPSS) 20.0. The sero-
positivity was considered as the number of  samples that 
tested positive to anti-HSV-1 and HSV-2 IgG antibodies 
over the number of  samples screened multiply by 100. 
Chi-square test was employed to define relationships 
among sociodemographic characteristics of  the partici-
pants. P<0.05 was set as the statistical significance level.
Results
Socio-demographic data 
The characteristics of  the pregnant women were strat-
ified and presented in Table 1. The median age in 
the samples was 30.5 years (range, 20 to 42). The age 
groups; 26 – 30 years and 31 – 35 years constituted the 
largest populations making up 40.6% (n=73) and 31.7% 
(n=57) of  the total population respectively, while 30 
(16.7%) of  the pregnant women were aged 20-25years 
and 20 (11.1%) were aged 36-42 years. Married pregnant 
women predominated the study constituting 98.3% of  
the sample compared to 1.7% of  the population that 
was single. On the basis of  educational background, 
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0.6%, 36.7%, 6.7% and 56.1% of  the pregnant wom-
en were found to have acquired primary, secondary, 
post-secondary and tertiary education respectively. A 
lower percentage of  13.3% were students and 37.8% 
were self  employed. While 22.8% of  them were gain-
fully employed, 26.1% were unemployed.
Seropositivity of  anti-HSV-1& HSV-2 IgG antibodies
From the 180 pregnant women examined, 179 (99.4%) 
women were seropositive for anti-HSV-1& HSV-2 IgG 
antibodies while 1 (0.6%) was seronegative for an-
ti-HSV-1& HSV02 IgG antibodies. Table 1 shows the 
characteristics of  the pregnant women tested and their 
serological outcomes.
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Total HSV-1 &-2 IgG Statistics 
No. % Positives  % Negatives  % 
Age 20-25 30 16.7 30 100.0 0 0.0  
 
26-30 73 40.6 73 100.0 0 0.0 χ2= 2.16995,  
 
31-35 57 31.7 56 98.2 1 1.8 df = 3, p>0.05 
 36-42 20 11.1 20 100.0 0 0.0  
Marital 
status Married 177 98.3 176 99.4 
1 0.6 χ2= 0.017,  
  Singles 3 1.7 3 100.0 0 0.0 df = 1, p<0.05 
Education Primary 1 0.6 1 100.0 0 0.0  
 
Secondary 66 36.7 66 100.0 0 0.0  
 
Post-
secondary 12 6.7 12 100.0 
0 0.0 χ2= 0.786548,  
 
Tertiary 101 56.1 100 99.0 1 1.0 df = 3, p>0.05 
Occupation Student 24 13.3 24 100.0 0 0.0  
 
Unemployed 47 26.1 46 97.9 1 2.1  
 
Self-
employed 68 37.8 68 100.0 
0 0.0 χ2= 2.8456,  
 Employed 41 22.8 41 100.0 0 0.0 df = 3, p>0.05 
Gestation 1st trimester 28 15.6 28 100.0 0 0.0  
 
2nd 
trimester 93 51.7 92 98.9 
1 1.1 χ2= 0.94071,  
 
3rd trimester 59 32.8 59 100.0 0 0.0 df = 2, p>0.05 
Total   180 100.0 179 99.4 1 0.6  
 
Seropositivity of  anti-HSV-1 & HSV-2 IgG anti-
bodies according to marital status
The seropositivity of  anti-HSV-1 & HSV-2 IgG anti-
bodies in accordance to the marital status is present-
ed in Figure 2. The three single pregnant women were 
found to be seropositive (100%) for HSV-1&2 while 
176 married women tested seropositive (99.4%). This 
difference was significantly associated (χ2= 0.017, 
df=1, p<0.05).
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Figure 1: Age-related seropositivity of anti-HSV-1 & HSV-2 IgG antibodies  
Age-related seropositivity of  anti-HSV-1 & HSV-2 
IgG antibodies
The age-related seropositivity of  anti-HSV-1 & HSV-2 
IgG antibodies is presented in Figure 1. Seropositivity 
of  100.0% was recorded in 20-25 years, 26-30 years and 
36-42 years age groups while 98.2% was found in age 
group 31-35 years. These differences was not statistical-
ly associated (χ2= 2.16995, df=3, p>0.05).
Seropositivity of  anti-HSV-1 & HSV-2 IgG anti-
bodies in relation to educational background
The educational background of  these pregnant women 
showed no significant association with seropositivity of  
anti-HSV-1 & HSV-2 IgG antibodies (χ2= 0.786548, 
df=3, p>0.05) as presented in Figure 3. One hundred 
percent (100.0%) of  the pregnant women having pri-
mary, secondary and post-secondary education had 
anti-HSV-1 & HSV-2 IgG antibodies while 99.0% se-
ropositivity was documented in those with tertiary edu-
cation (Table 1, Figure 3). 
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Figure 2: Marital status-related seropositivity of anti-HSV-1 & HSV-2 IgG antibodies  
Occupation-related seropositivity of  anti-HSV-1 & 
HSV-2 IgG antibodies
Occupation-related seropositivity of  anti-HSV-1 & 
HSV-2 IgG antibodies is presented in Figure 4. The 
pregnant women that were students, self  employed and 
employed were all seropositive for anti-HSV-1 & HSV-2 
having 100.0% seropositivity in each group while those 
that were unemployed had 97.9% seropositivity (46 of  
47). However, these differences were not significantly 
related (χ2= 2.8456, df  = 3, p>0.05).
African Health Sciences Vol 15 Issue 3, September 2015      742
 
Figure 3: Seropositivity of anti-HSV1 & HSV-2 IgG antibodies in relation to 
educational background 
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Seropositivity of  anti-HSV-1 & HSV-2 IgG anti-
bodies in relation to gestation period 
Gestation period related seropositivity of  anti-HSV-1 
& HSV-2 IgG antibodies is presented in Figure 5. It 
showed that participants in first and third trimesters 
had 100.0% seropositivity compared to those in their 
second trimester (98.9%). Nevertheless, this difference 
was not significantly associated (χ2= 0.94071, df  = 2, 
p>0.05).
 
Figure 4: Occupation-related seropositivity of anti-HSV-1 & HSV-2 IgG antibodies 
Discussion
HSV-1 and HSV-2 is a frequently occurring STI, and its 
prevalence has rose considerably in the past two eras 
in several advanced and developing countries2,9. Known 
co-factors for HSV transmission include race, sex, age, 
frequency of  sexual contacts, non-use of  condom, du-
ration of  relationship, history of  STI, duration of  HSV 
in the source partner, HIV infection, socioeconomic 
status and serological outcomes10-13.
This study aimed at determining the seropositivity and 
determinants of  anti-HSV-1 and HSV-2 IgG antibodies 
among pregnant women in Port Harcourt, Rivers State, 
South-South region of  Nigeria and also to identify the 
demographic variables associated with the prevalence. 
Very high infection levels have been documented in the 
developing world of  which Nigeria is one of  them. Co-
rey and Handsfield14 reported rates of  60 - 90% among 
gold miners and commercial sex workers respectively 
in South Africa. Prevalence rates ranging from 30 to 
80% have been recorded among women in sub-Saharan 
Africa15. In Nigeria, Agabi et al.16 observed 87.0% prev-
alence in Jos, Nigeria. Kurewa et al.17 reported a preva-
lence of  51.1% among pregnant women in Zimbabwe. 
Though only pregnant women were used in this study, 
African Health Sciences Vol 15 Issue 3, September 2015      744
previous studies have shown that females were more 
prone to HSV infection than their male counterparts7. 
Conversely, in pregnant women, the danger related with 
mother-child transmission of  HSV has turn into a key 
public health concern 9,18-19. Genital infection by HSV-1 
and HSV-2 amongst pregnant females is a main cause 
for apprehension because of  the danger it poses to 
the fetus and newborns18-19. Therefore, the assessment 
of  HSV infection in pregnant women will help in the 
proper management of  the infection and will also be 
useful for epidemiological purposes.
Anti-HSV-1 and HSV-2 IgG antibodies and its conno-
tation with certain risk and sociodemographic factors 
have been previously reported. This study revealed a 
high seropositivity rate (99.4%) of  anti-HSV-1 and 
HSV-2 antibodies amongst pregnant women. HSV 
is most predominant among adult population; conse-
quently2,9, several females have been exposed in ad-
vance to pregnancy2,9, eliciting the fact that most of  
the pregnant women have been open to each HSV-1 or 
HSV-2 or both that ensued in infection and formation 
of  antibody2,9. This goes ahead to suggest a pointer of  
the possibility of  HSV transmission amongst sexually 
active females2,9. This high rate is in concordance with 
various studies performed. 
 
Figure 5: Gestation period related seropositivity of HSV 1&2 IgG antibodies  
Ghazi et al.20 detected a high seropositivity of  90.9% 
and 27.1% for HSV-1 and HSV-2 IgG antibodies re-
spectively in pregnant Saudi women. Also, Sauerbrei et 
al.21 found 82.0% and 18% of  the pregnant women se-
ropositive for HSV-1 and -2 type specific IgG antibod-
ies respectively. In the United States, Xu et al.2 reported 
a 72% overall seropositivity of  HSV amongst pregnant 
women. The 99.4% seropositivity for HSV in this study 
is higher than previously reported by some other au-
thors. It is higher than 29.08% obtained by Apurba et 
al.22 and 18.6% reported by Sadiq et al.23 among preg-
nant mothers with bad obstetric history.
The serological status of  the pregnant women in the 
present study was compared with socio-demographic 
variables such as age, marital status, education, occupa-
tions and gestation period. All the variables appeared to 
be statistically insignificantly associated (P> 0.05) with 
the prevalence of  HSV IgG antibodies among the sam-
ples investigated except for marital status which was 
significantly associated with HSV IgG. This finding is 
similar to that obtained by Obeid24 in a study among 
pregnant women in Saudi Arabia who observed that 
there was no statistically significant association between 
age and occupation, and HSV-1 IgG. Obeid24 also ob-
served that education was not significantly associated 
with HSV-2 IgG. Another study by Rezaei-Chaparpordi 
et al.25 found a significant correlation between age, mar-
ital status, occupation, and HSV seroprevalence. Kure-
wa et al.17 also reported that the danger for a seroposi-
tive STI rises with number of  lifetime sexual partners, 
increasing ages greater than 30 years, multigravid, po-
lygamy, partner taking alcohol and age at sexual debut.
In previous studies, seropositivity of  HSV rose stead-
ily with age through the age range or subsequently in-
creased above age 3026. Consequently, it drops in older 
females greater than 40 years of  age26. However, in the 
present study, a total prevalence rate of  100.0% was ob-
served in the pregnant women from ages 20-25 years, 
26-30 years and 36-42 years, with a slight decrease in 
ages 31-35 years. A maximum number of  HSV sero-
positivity observed in age group 26-30 years is in cogni-
zance with a study by Apurba et al.22. 
A higher prevalence was recorded among the single 
than married pregnant women (100.0% versus 99.4%) 
which agrees with Agabi et al.16 that also found a high-
er prevalence in singles compared to married individu-
als. This indicates that the single pregnant women in-
cluded in this study should have had a greater lifetime 
sexual activity or have been infected in early childhood 
more than the married women. This results deviates 
from the higher prevalence rate of  71.2% observed by 
Rezaei-Chaparpordi et al.25 among subjects that were 
married than the singles in a study determining sero-
prevalence of  HSV in Iran.
This study also showed a higher prevalence of  HSV 
infection for pregnant women with lower educational 
status (100.0% for primary, secondary and post-second-
ary education) than those with tertiary education. This 
agrees with Malkin et al.27who found a higher HSV-1 
infection in people of  lower education level in France. 
Rezaei-Chaparpordi et al.25 also observed an increase in 
prevalence of  HSV antibodies with a decrease in level 
of  education. It can be deduced from the present study 
that a higher risk of  HSV is associated with a lower 
level of  education. This might be explained by the fact 
that a lower level of  education was an indicator of  low 
socioeconomic status which was a risk factor for HSV 
infection. Lack of  proper education might give rise to 
ignorance of  HSV acquisition and prevention. Also, 
enlightenment on the significance of  HSV diagnosis, 
treatment and preventive measures might aid the con-
trol of  HSV-2 transmission.
A high prevalence of  HSV IgG was observed in all oc-
cupational groups. This might be explained by the fact 
that a lower level of  occupation (unemployed in this 
study) was an indicator of  low socioeconomic status 
which was a risk factor for HSV infection. This ob-
servation deviates from a high seroprevalence found 
in lower socioeconomic group than in high socio-eco-
nomic group according to studies performed by Apur-
ba et al. 22 and Sadiq et al.23. The absence of  a significant 
relationship found between education, occupation, and 
HSV seropositivity in this study compares favourably 
with Weiss15 who stated that educational status, so-
cio-economic (including occupation) and religion had 
insignificant outcome on the seropositivity of  HSV-1 
and HSV-215. 
A high prevalence rate was also found for pregnant 
women in their first and third trimester. This suggests 
that these groups of  females were at a greater danger of  
African Health Sciences Vol 15 Issue 3, September 2015745
acquiring HSV27 for instance, HSV gotten in the course 
of  pregnancy is connected with spontaneous abortion27 
which occur highest in first trimesters, and risk of  ne-
onatal transmission with highest risk occurring at third 
trimester. The study also showed a seronegativity of  
0.6% among the pregnant women tested and is there-
fore at high risk and vulnerable to suffering a primary 
genital herpes. The danger of  mother to child spread 
of  HSV is utmost if  a seronegative female acquire pri-
mary or secondary genital herpes close to the delivery, 
preceding to antibody development. 
Conclusion
This study has confirmed the seropositivity of  immu-
noglobulin –G (IgG) against HSV-1 and -2 among preg-
nant women. It also showed that the seropositivity of  
anti-HSV-1 and HSV-2 IgG antibodies among pregnant 
women in Port Harcourt, Nigeria is very high (99.4%). 
The study also showed that age, education, occupation 
and gestation period were insignificantly linked to HSV 
IgG seropositivity. However, the seropositivity of  HSV 
IgG was significantly associated with marital status. It 
be deduced that the risk of  unborn children contracting 
HSV would be greater in cases where pregnant women 
exhibit no immunity i.e. no antibodies. From the find-
ings of  this study conducted in Port Harcourt, Nigeria, 
pregnant women should be educated on the risks of  
neonatal herpes, particularly since they are likely to have 
the strongest motivation for avoiding infection from 
partners. HSV serological testing of  women should 
be included as a routine test during pregnancy in Ni-
geria, not only to identify those at risk of  acquisition, 
but also to observe the prevalence rates. To the best 
of  our knowledge, the findings of  this study is the first 
documented seropositivity of  anti-HSV-1 and HSV-2 
IgG antibodies among pregnant women in Port Har-
court, Nigeria which provides a baseline data for future 
in-depth studies on HSV infection in South South, Ni-
geria. 
Acknowledgement 
The authors wishes to appreciate the management and 
staff  of  Braithwaite Memorial Specialist Hospital, Port 
Harcourt, Nigeria for their approval and assistance dur-
ing this study. The exceptional technical support of  
Miss EM Okoli and Miss EJ Anah amongst others is 
also appreciated.
References
1. Brugha, R., Keersmaekers, K., and Renton A. Genital 
herpes infection: a review. International Journal of  Epide-
miology, 1997; 26: 698-709. 
2.  Xu, F., Sternberg, M.R., Kottiri, B.J., McQuillan, 
G.M., Lee, F.K., Nahmias, A.J., Berman, S.M. and 
Markowitz, L.E. Trends in herpes simplex virus type1 
and type 2, seroprevalence in the United States. Journal 
of  American Medical Association, 2006; 296 (8): 964-973.
3.  Cusini, M., and Ghislanzoni, M. The importance of  
diagnosing genital herpes. Journal of  Antimicrobial Chemo-
therapy, 2001; 47:9-16.
4.  Mbopi-Keou, F.X., Robinson, N.J., Mayaud, P., Be-
lec, L., and Brown, D. W.G. Herpes simplex virus type 
2 and heterosexual spread of  human immunodeficiency 
virus infection in developing countries: hypothesis and 
research priorities. Clinical Microbiology and Infectious 
Diseases, 2003; 9: 161-171. 
5. Celum, C. L. The Interaction between Herpes Sim-
plex Virus and Human Immunodeficiency Virus. Her-
pes, 2004; 1: 36A-44A.
6. Brown, Z.A., Selke, S., Zeh, J., Kopelman, J., Maslow, 
A., Ashley, R.L., Watts, D.H., Berry, S., Herd, M. and 
Corey, L. The acquisition of  herpes simplex virus dur-
ing pregnancy. New England Journal of  Medicine, 1997; 
337(8): 509–515.
7.  Looker, K.L., Garnetta, G.P. and Schmid, G.P. An es-
timate of  the global prevalence and incidence of  herpes 
simplex virus type 2 infection. Bulletin of  the World 
Health Organization, 2008: 86 (10): 805–812.
8. Slomka MJ. Seroepidemiology and control of  genital 
herpes: the value of  type specific antibodies to herpes 
simplex virus. Communicable Disease Report, 1996; 
volume 6, Review No. 3: R41. ISSN:1350-9349
9. Kriebs, J.M. Understanding herpes simplex virus: 
transmission, diagnosis, and considerations in pregnan-
cy management. Journal of  Midwifery and Womens Health, 
2008; 53: 202-208.
10.  Whitley, R.J. Herpes Simplex Viruses. In: Knipe 
DM, Howley PM, Griffin DE, et al eds. Fields Virolo-
gy. 4th edition, Volume 2. New York, Lippincott, 2001; 
2461-2509.
11. Stock, C., Guillén-Grima, F., de Mendoza, J.H., 
Marin-Fernandez, B., Aguinaga-Ontoso, I. and Krämer, 
A. Risk factors of  herpes simplex type 1 (HSV-1) infec-
tion and lifestyle factors associated with HSV-1 man-
ifestations. European Journal of  Epidemiology, 2001; 17: 
885-890.
African Health Sciences Vol 15 Issue 3, September 2015      746
12. Clemens, S.A and Farhat, C.K. Seroprevalence of  
herpes simplex 1-2 antibodies in Brazil. Revista de 
Saúde Pública, 2010; 44: 726-734.
13. Stowe, R.P., Peek, M.K., Perez, N.A., Yetman, D.L., 
Cutchin, M.P. and Goodwin, J.S. Herpes virus reactiva-
tion and socioeconomic position: A community-based 
study. Journal of  Epidemiology and Community Health, 2010; 
64: 666-671.
14. Corey, L. and Handsfield, H.H. Gential herpes and 
public health: Addressing a global problem. Journal of  
the American Medical Association, 2000; 283: 791-794.
15. Weiss, H. Epidemiology of  herpes Simplex Virus 
Type-2 infections in the developing world. Herpes, 
2004; 11: 24A-35A.
16. Agabi, Y.A., Banwat, E.B., Mawak, J.D., Lar, P.M., 
Dashe, N., Dashen, M.M., Adoga, M.P., Agabi, F.Y. 
and Zakari, H. Seroprevalence of  herpes simplex virus 
type-2 among patients attending the Sexually Transmit-
ted Infections Clinic in Jos, Nigeria. Journal of  Infection in 
Developing Countries, 2010; 4(9): 572-575.
17. Kurewa NE; Mapingure MP; Munjoma MW; Chiren-
je MZ; Rusakaniko S; Stray-Pedersen B. The burden 
and risk factors of  Sexually Transmitted Infections and 
Reproductive Tract Infections among pregnant women 
in Zimbabwe. BMC Infectious Diseases, 2010; 10:127. 
18. Baker, D.A. Consequences of  herpes simplex virus 
in pregnancy and their prevention. Current Opinion in 
Infectious Diseases, 2007; 20: 73-76.
19. Sauerbrei. A. and Wutzler, P. Herpes simplex and 
varicella-zoster virus infections during pregnancy: cur-
rent concepts of  prevention, diagnosis and therapy. 
Part 1: herpes simplex virus infections. Medical Micro-
biology and Immunology, 2007; 196: 89-94.
20. Ghazi, H. O., Telmesani, A. M. and Mahomed, M. 
F. TORCH agents in pregnant Saudi women. Medical 
Principles and Practice, 2002; 11(4): 180-182.
21. Sauerbrei A., Schmitt, S., Scheper, T., Brandstädt. 
A., Saschenbrecker, S., Motz, M., Soutschek, E. and 
Wutzler, P. Seroprevalence of  Herpes Simplex Virus 
Type 1 and type 2 in Thuringia, Germany, 1999 to 2006. 
Eurosurveillance, 2011; (16):44, http://www.eurosur-
veillance.org/ViewArticle.aspx?ArticleId=20005
22. Apurba, S.S., Sandhya B.K., Senthamarai S., 
Sivasankari S., Kumudavathi M.S., Anitha C. and Am-
shavathani S.K. (2013). Serological Evaluation of  Her-
pes Simplex Virus Type- 1/ Type- 2 Infections in Preg-
nant Women with Bad Obstetric History in a Tertiary 
Care Hospital, Kanchipuram. International Journal of  Ad-
vanced Research, 2013; 1(3): 123-128.
23. Sadiq, M.S, Fatima, H., Jamil, K. and Patil, C. Study 
of  TORCH profile in patients with bad obstetric histo-
ry. Biology and Medicine, 2012; 4(2): 95-101. 
24. Obeid, O.E. Prevalence of  herpes simplex virus 
types 1 and 2 and associated sociodemographic varia-
bles in pregnant women attending king fahd hospital 
of  the university (2007). Journal of  Family and Community 
Medicine, 2007; 14(1): 3-7.
25. Rezaei-Chaparpordi, S., Assmar, M., Amirmozafari, 
N., Modiri, L., Massiha, A., Shokri-Fashtali, S., Gholi-
zadeh, Z. and Akbari, S. Seroepidemiology of  Herpes 
Simplex Virus Type 1 and 2 in Northern Iran. Iranian 
Journal of  Public Health, 2012; 41(8): 75-79. 
26. Smith, J.S. and Robinson, N.J. Age-specific preva-
lence of  infection with herpes simplex virus types 2 and 
1: a global review. Journal of  Infectious Diseases, 2002; 186: 
3–28.
27. Malkin, J.E., Morand, P., Malvy, D., Ly, T. D., Chan-
zy, B. De Labareyre, C., El Hasnaoui, A. and Hercberg, 
S. Seroprevalence of  HSV-1 and HSV-2 infection in the 
general French population. Sexually Transmitted Infec-
tions, 2002; 78: 201–203.
 
African Health Sciences Vol 15 Issue 3, September 2015747
